FAKTOR OPTIONSSCHEIN - BOSTON SCIENTIFIC | Real-time BOERSE MUENCHEN 03:01:07 2024-06-17 am EDT | ||
| 58.3 EUR | +6.10% |
|
| Current month | +14.57% | ||
| 1 month | +26.15% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
| Date | Price | Change |
|---|---|---|
| 24-06-17 | 58.3 | +6.10% |
| 24-06-14 | 54.95 | +2.21% |
| 24-06-13 | 53.76 | -4.95% |
| 24-06-12 | 56.56 | +2.26% |
| 24-06-11 | 55.31 | -0.50% |
Real-time BOERSE MUENCHEN
Last update June 17, 2024 at 03:01 am EDT
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | Goldman Sachs |
| WKN | GK47P9 |
| ISIN | DE000GK47P99 |
| Date issued | 2022-05-11 |
| Strike | 61.41 $ |
| Maturity | Unlimited |
| Parity | 0.26 : 1 |
| Emission price | 9.99 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 59.19 € |
|---|---|
| Lowest since issue | 5.65 € |
| Spread | 1 € |
| Spread % | 1.80% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
76.76
USD
Average target price
82.26
USD
Spread / Average Target
+7.16%
- Stock Market
- Certificates
- Certificat
